Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody

Zhisheng Her1, Terk-Shin Teng2, Jeslin J L Tan2

  • 1Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore, Singapore Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

EMBO Molecular Medicine
|December 3, 2014
PubMed